Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
- PMID: 27185810
- PMCID: PMC5407171
- DOI: 10.1093/ije/dyw061
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
Abstract
Background: To assess the worldwide variation of amyotrophic lateral sclerosis (ALS) incidence, we performed a systematic review and meta-analysis of population-based data published to date.
Methods: We reviewed Medline and Embase up to June 2015 and included all population-based studies of newly diagnosed ALS cases, using multiple sources for case ascertainment. ALS crude and standardized incidence (on age and sex using the US 2010 population) were calculated. Random effect meta-analysis and meta-regression were performed using the subcontinent as the main study level covariate. Sources of heterogeneity related to the characteristics of the study population and the study methodology were investigated.
Results: Among 3216 records, 44 studies were selected, covering 45 geographical areas in 11 sub-continents. A total of 13 146 ALS cases and 825 million person-years of follow-up (PYFU) were co-nsidered. The overall pooled worldwide crude ALS incidence was at 1.75 (1.55-1.96)/100 000 PYFU; 1.68 (1.50-1.85)/100 000 PYFU after standardization. Heterogeneity was identified in ALS standardized incidence between North Europe [1.89 (1.46-2.32)/100 000 PYFU] and East Asia [0.83 (0.42-1.24)/100 000 PYFU, China and Japan P = 0.001] or South Asia [0.73 (0.58-0.89)/100 000/PYFU Iran, P = 0.02]. Conversely, homogeneous rates have been reported in populations from Europe, North America and New Zealand [pooled ALS standardized incidence of 1.81 (1.66-1.97)/100 000 PYFU for those areas].
Conclusion: This review confirms a heterogeneous distribution worldwide of ALS, and sets the scene to sustain a collaborative study involving a wide international consortium to investigate the link between ancestry, environment and ALS incidence.
Keywords: Amyotrophic lateral sclerosis; epidemiology; ethnic groups; incidence.
© The Author 2016. Published by Oxford University Press on behalf of the International Epidemiological Association
Figures




Similar articles
-
Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review.Neurology. 2023 Aug 8;101(6):e613-e623. doi: 10.1212/WNL.0000000000207474. Epub 2023 Jun 12. Neurology. 2023. PMID: 37308302 Free PMC article.
-
Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.Eur J Epidemiol. 2016 Mar;31(3):229-45. doi: 10.1007/s10654-015-0090-x. Epub 2015 Oct 12. Eur J Epidemiol. 2016. PMID: 26458931
-
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD004427. doi: 10.1002/14651858.CD004427.pub4. Cochrane Database Syst Rev. 2017. PMID: 28982219 Free PMC article.
-
Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD006049. doi: 10.1002/14651858.CD006049.pub2. Cochrane Database Syst Rev. 2017. PMID: 28067943 Free PMC article.
-
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).Cochrane Database Syst Rev. 2002;(2):CD001447. doi: 10.1002/14651858.CD001447. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001447. doi: 10.1002/14651858.CD001447.pub2. PMID: 12076411 Updated.
Cited by
-
Elevation of inositol pyrophosphate IP7 in the mammalian spinal cord of amyotrophic lateral sclerosis.Front Neurol. 2024 Jan 11;14:1334004. doi: 10.3389/fneur.2023.1334004. eCollection 2023. Front Neurol. 2024. PMID: 38274887 Free PMC article.
-
New insight on microglia activation in neurodegenerative diseases and therapeutics.Front Neurosci. 2023 Dec 22;17:1308345. doi: 10.3389/fnins.2023.1308345. eCollection 2023. Front Neurosci. 2023. PMID: 38188026 Free PMC article. Review.
-
The Global Burden of Motor Neuron Disease: An Analysis of the 2019 Global Burden of Disease Study.Front Neurol. 2022 Apr 21;13:864339. doi: 10.3389/fneur.2022.864339. eCollection 2022. Front Neurol. 2022. PMID: 35528743 Free PMC article.
-
Elaborate Tongue Fasciculations Going Down to the Neck: A Rare Case of Sporadic, Young-onset Amyotrophic Lateral Sclerosis with Bulbar Symptoms, from Pakistan.Cureus. 2019 May 5;11(5):e4600. doi: 10.7759/cureus.4600. Cureus. 2019. PMID: 31431830 Free PMC article.
-
CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.Syst Rev. 2018 Dec 20;7(1):237. doi: 10.1186/s13643-018-0913-4. Syst Rev. 2018. PMID: 30572951 Free PMC article.
References
-
- Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007;68: 1002-07. - PubMed
-
- Joensen P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand 2012;126:62-66. - PubMed
-
- Murphy M, Quinn S, Young J, Parkin P, Taylor B.. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 2008;71:1889-95. - PubMed
-
- Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE.. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. JAMA Neurol 2013;70:476-80. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous